Instil Bio (TIL) Accounts Payables (2020 - 2026)
Instil Bio (TIL) posted quarterly Accounts Payables of $793000.0 for Q1 2026, up 177.27% year-over-year from $286000.0 in Q1 2025, and up 1.8% quarter-over-quarter from $779000.0 in Q4 2025.
Instil Bio (TIL) Accounts Payables (2020 - 2026) Analysis & Trends
Instil Bio's Accounts Payables history runs 7 years deep, the most recent figure standing at $793000.0 for Q1 2026.
- In Q1 2026, Accounts Payables rose 177.27% year-over-year to $793000.0; the TTM figure through Mar 2026 stood at $793000.0 (up 177.27% YoY), while the FY2025 annual figure was $779000.0, up 18.21% from the prior year.
- Accounts Payables for Q1 2026 stood at $793000.0, up from $779000.0 in the prior quarter.
- The five-year high for Accounts Payables was $7.7 million in Q1 2022, with the low at $286000.0 in Q1 2025.
- The 5-year median for Accounts Payables is $1.2 million (2024), against an average of $2.1 million.
- The sharpest annual moves came in 2023 and 2026: Accounts Payables plunged 82.51% in 2023, then jumped 177.27% in 2026.
- Instil Bio's Accounts Payables stood at $2.4 million in 2022, then tumbled by 48.62% to $1.2 million in 2023, then tumbled by 45.63% to $659000.0 in 2024, then rose by 18.21% to $779000.0 in 2025, then gained by 1.8% to $793000.0 in 2026.
- Business Quant data shows TIL's Accounts Payables at $793000.0 in Q1 2026, $779000.0 in Q4 2025, and $928000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | 35.57 Mn |
| 10 | Instil Bio | 53.44 Mn | 53.44 Mn | - | 795,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 795,000.00 |
| Mar 31, 2026 | 793,000.00 |
| Dec 31, 2025 | 779,000.00 |
| Sep 30, 2025 | 928,000.00 |
| Jun 30, 2025 | 523,000.00 |
| Mar 31, 2025 | 286,000.00 |
| Dec 31, 2024 | 659,000.00 |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.22 Mn |
| Mar 31, 2024 | 1.23 Mn |
| Dec 31, 2023 | 1.21 Mn |
| Sep 30, 2023 | 1.65 Mn |
| Jun 30, 2023 | 2.16 Mn |
| Mar 31, 2023 | 1.35 Mn |
| Dec 31, 2022 | 2.36 Mn |
| Sep 30, 2022 | 5.33 Mn |
| Jun 30, 2022 | 5.79 Mn |
| Mar 31, 2022 | 7.71 Mn |
| Dec 31, 2021 | 5.57 Mn |
| Sep 30, 2021 | 5.25 Mn |